Synta Pharmaceuticals (SNTA) Posts Narrower than Expected Q2 Loss of 25c/Share
Tweet Send to a FriendGet Alerts SNTA Hot Sheet
Price: $7.50 +0.13%
EPS Growth %: -11.1%
Financial Fact:
General and administrative: 3.88M
Today's EPS Names:
ZIOP, TIVO, QIHU, More
EPS Growth %: -11.1%
Financial Fact:
General and administrative: 3.88M
Today's EPS Names:
ZIOP, TIVO, QIHU, More
Trade SNTA Now!
Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) reported Q2 EPS of ($0.25), $0.02 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Synta Pharmaceuticals, Inc. (SNTA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Synta Pharmaceuticals, Inc. (SNTA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Euroseas Ltd. (ESEA) Posts Q1 Loss of 10c/Share
- Macy's (M) Posts Q1 EPS of 55c; Comps Up 3.8%; Boosts Dividend 25%, Raises Buyback
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
